Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

B J Brew

Showing results (11-20 of 109) with videos related to

Pageof 11
Sort By:
Current Opinion in Neurology|June 1, 1994
The clinical spectrum and pathogenesis of HIV encephalopathy, myelopathy, and peripheral neuropathyB J Brew
AIDS (London, England)|October 2, 2001
Markers of AIDS dementia complex: the role of cerebrospinal fluid assaysB J Brew
Australian and New Zealand Journal of Medicine|October 1, 1986
Diagnosis of Wernicke's encephalopathyB J Brew
Journal of Neurology, Neurosurgery, and Psychiatry|December 16, 2000
HTLV-I and HIV infection of the CNS in tropical areasB J Brew
Journal of Acquired Immune Deficiency Syndromes|January 1, 1993
HIV-1-related neurological diseaseB J Brew
Muscle & Nerve|October 23, 2003
The peripheral nerve complications of human immunodeficiency virus (HIV) infectionB J Brew
Australian and New Zealand Journal of Medicine|April 1, 1990
Prognosis of patients ... myelopathy of unknown originB J Brew
Lancet (London, England)|December 24, 1998
HIV-1 peripheral neuropathy and combination antiretroviral therapyR Markus, B J Brew
Neurology|November 23, 2000
Decreasing incidence of CNS AIDS defining events associated with antiretroviral therapyB J Brew, G Dore
The American Journal of Medicine|September 1, 1996
Human immunodeficiency virus type 1-related transient neurological deficitsB J Brew, J Miller
Pageof 11

Showing results (11-20 of 109) with videos related to

Sort By:
Pageof 11
Current Opinion in Neurology|June 1, 1994
The clinical spectrum and pathogenesis of HIV encephalopathy, myelopathy, and peripheral neuropathyB J Brew
AIDS (London, England)|October 2, 2001
Markers of AIDS dementia complex: the role of cerebrospinal fluid assaysB J Brew
Australian and New Zealand Journal of Medicine|October 1, 1986
Diagnosis of Wernicke's encephalopathyB J Brew
Journal of Neurology, Neurosurgery, and Psychiatry|December 16, 2000
HTLV-I and HIV infection of the CNS in tropical areasB J Brew
Journal of Acquired Immune Deficiency Syndromes|January 1, 1993
HIV-1-related neurological diseaseB J Brew
Muscle & Nerve|October 23, 2003
The peripheral nerve complications of human immunodeficiency virus (HIV) infectionB J Brew
Australian and New Zealand Journal of Medicine|April 1, 1990
Prognosis of patients ... myelopathy of unknown originB J Brew
Lancet (London, England)|December 24, 1998
HIV-1 peripheral neuropathy and combination antiretroviral therapyR Markus, B J Brew
Neurology|November 23, 2000
Decreasing incidence of CNS AIDS defining events associated with antiretroviral therapyB J Brew, G Dore
The American Journal of Medicine|September 1, 1996
Human immunodeficiency virus type 1-related transient neurological deficitsB J Brew, J Miller
Pageof 11